Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

VNDAVNDA
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in VANDA PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 1M shares of VNDA (VANDA PHARMACEUTICALS INC), worth $6.3M as of 2026-Q2. The position was increased (+23.6% shares). VNDA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$6.3M

Current Shares

1M

Total Value Change

+$6.3M

Total Shares Change

-796,421

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+23.6%
$6.3M0.0%$6.12
33
2026-Q1
Increased
838,233
+105.3%
$5.8M0.0%$6.91
44
2025-Q4
Increased
408,342
+20.2%
$3.6M0.0%$8.82
32
2025-Q3
Decreased
339,701
-16.5%
$1.7M0.0%$4.99
0
2025-Q2
Decreased
406,731
-41.4%
$1.9M0.0%$4.72
0
2025-Q1
Decreased
693,852
-11.9%
$3.2M0.0%$4.59
0
2024-Q4
Increased
787,817
+3.6%
$3.8M0.0%$4.79
28
2024-Q3
Increased
760,358
+113.3%
$3.6M0.0%$4.69
43
2024-Q2
Decreased
356,546
-29.4%
$2M0.0%$5.65
0
2024-Q1
Increased
505,385
+9.6%
$2.1M0.0%$4.11
28
2023-Q4
Decreased
461,213
-72.4%
$1.9M0.0%$4.22
0
2023-Q3
Decreased
1.7M
-20.5%
$7.2M0.0%$4.32
0
2023-Q2
Increased
2.1M
+27.4%
$13.9M0.0%$6.59
35
2023-Q1
Increased
1.7M
+10.7%
$11.2M0.0%$6.79
31
2022-Q4
Decreased
1.5M
-12.5%
$11M0.0%$7.39
0
2022-Q3
Decreased
1.7M
-7.0%
$16,8440.0%$9.88
0
2022-Q2
First report
1.8M
-
$19,9760.0%$10.90
0

Other major holders of VNDA: BNP PARIBAS FINANCIAL MARKETS, RENAISSANCE TECHNOLOGIES LLC, MACQUARIE GROUP LTD, BlackRock, Inc., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used